Aims: The development of left ventricular hypertrophy (LVH) can be affected by diet 20 manipulation. Concentric LVH resulting from pressure overload can be worsened by 21 feeding rats with a high-fructose diet. Eccentric LVH is a different type of hypertrophy 22 and is associated with volume overload (VO) diseases. The impact of an abnormal diet 23 on the development of eccentric LVH and on ventricular function in chronic volume 24 overload is unknown. This study therefore examined the effects of a fructose-rich diet on 25 left ventricular eccentric hypertrophy, ventricular function and myocardial metabolic 26 enzymes in rats with chronic VO caused by severe aortic valve regurgitation (AR). 27
Introduction 44
Chronic left ventricular volume overload (VO) causes severe left ventricular dilatation 45 and eccentric hypertrophy. This type of left ventricular hypertrophy is encountered 46 mainly in patients with valvular diseases such as chronic mitral (MR) or aortic valve 47 9 enzymatic assay. The activity was determined in the following reaction medium (1.1mL) 159 (500mM potassium phosphate pH7.5, 50mg/ml BSA, 25mM decyubiquinone); 22.5µl of 160 LV homogenate were added to reaction medium followed by a 5-min incubation at 37°C. 161
The reaction was then initiated by adding NADH to a final concentration of 50μM. 162
Enzyme activity was estimated by the reduction of NADH to NAD + in a 163 spectrophotometer with wavelength set at 340nm. To measure the specific complex I 164 activity, the same experiment was performed in presence of 2.5mM rotenone, an 165 inhibitor of complex I. Subtraction of NADH oxidase activity measured with rotenone to 166 the one measured without represent specific complex I activity. Succinate 167 dehydrogenase (SDH) activity was measured on small pieces of LV (20-30 mg) 168 homogenized in 10 volumes of a Tris-sucrose buffer (Tris 20mM pH 7.2, 0.8M sucrose, 169 2mM EGTA, 40 mM KCl and 1mg/ml BSA (bovine serum albumin). Four µl of the 170 cleared homogenate were then added to 194.4µL of reaction buffer (50mM KH 2 PO 4 171 solution (pH7.2), 10 mM succinate, 1mg/ml BSA, 140µM sodium 2, 6-172 dichloroindophenolate (DCIP), 0.2mM KCN (0.2mM), 8µM rotenone). A parallel reaction 173 was also performed in presence of 10mM malonate, a SDH inhibitor. Reaction was 174 incubated for 10 minutes at 37°C then decylubiquinone (100 µM in assay) was added to 175 the mix. Rate of DCIP reduction was then measured on a spectrophotometer set at 600 176 nm for 5 min every 15 seconds. Rate of DCIP reduction was then calculated in presence 177
or not of malonate in order to deduce SDH activity (16) . 178
Immunoblotting 180
Crude LV homogenates were separated by SDS-PAGE. Volumes of samples loaded on 181 gel were corrected for the amount of protein. Immunoblotting was performed as 182 described elsewhere (33). Membranes were hybridized with the indicated primary 183
antibodies. All primary antibodies were used at a 1:1000 dilution and were purchased 184 from Cell Signaling Technology (Beverly, MA). Bands were visualized and quantified 185 with a ChemiImager system (Alpha Innotech Corporation). 186
187

Statistical analysis 188
Results are presented as mean ± SEM unless specified otherwise. Inter-group 189 comparisons were done using two-way ANOVA and using Bonferroni post-test when 190 indicated. Statistical significance was set at a p<0.05. Data and statistical analysis were 191 performed using Graph Pad Prism version 5.02 for Windows, Graph Pad Software (San 192
Diego CA). 193 194
Results
195
Clinical data and animal characteristics (Table 1) : 196
All animals were alive at the end of the protocol. Fructose-fed rats (SF and ARF) had a 197 slightly lower body weight compared to their respective controls (SC and ARC) at the 198 end of the protocol although overall growth was similar as demonstrated by the 199 comparable tibial lengths in all groups (Table 1) . ARC had less retroperitoneal fat than 200 the ARF animals. As illustrated in Figure 1a , fructose-fed animals (SF and ARF) had a 201 lower caloric intake than animals on control diet. 202
As expected, heart weight was strongly increased in both AR groups compared to the 203 sham-operated groups. The ARF had an increased total heart weight compared to ARC. 204
This was due an increase in LV mass in the ARF group. Right ventricular, left atrial and 205 lung weights were also increased in ARC and ARF but the diets did not affect these 206
measurements. 207
Plasma glucose levels (Fig. 1b) were similar between all groups with the exception of 208 the ARF group which tended to have higher glucose levels (p=0.07) but this difference 209 did not reach statistical significance. Triglyceride levels were strongly increased in both 210 fructose-fed groups (SF and ARF) as expected with this diet composition (Fig. 1c) . 211
Insulin, leptin and adiponectin levels remained similar between groups (Figure 1d-e) . 212
There was a trend towards a diet-disease interaction for the insulin levels (p=0.06) but 213 again the difference did not reach statistical significance. 214 215 Echocardiographic (table 2) and hemodynamic (table 3) 
data 216
As expected, severe aortic valve regurgitation led to enlarged end-diastolic and end-217 systolic dimensions in both groups (ARC and ARF) ( Table 2) . ARF had larger end-218 systolic diameters and slightly lower systolic ejection fraction than ARC. LV mass 219 estimated by echo was significantly increased in ARF compared to ARC and therefore 220 corroborated well with the direct measurement of heart weight at sacrifice. 221 AR severity was similar in both ARC and ARF groups (results not shown). Heart rate 222 was slightly lower in the ARC and ARF groups. AR also resulted as expected in larger 223 and similar forward stroke volumes and increased cardiac output in those groups (Table  224 3). End-diastolic LV pressure was significantly higher in ARC and ARF compared to their 225 respective sham controls. There was however no clear diet effect on this parameter. 226
There was no diet effect or diet-disease interaction for any of the measured 227 hemodynamic parameters between the ARC and ARF groups. 228
Markers of LV remodeling 230
As illustrated in Figure 2 , the gene expression of two markers of LV hypertrophy (atrial 231 and brain natriuretic factors (ANP and BNP)) were increased in both AR groups. There 232 was no diet effect or diet-disease interaction on these parameters. 233
Interstitial fibrosis is a late feature in our model (22; 32). Standard LV tissue staining for 234 the quantification of fibrosis did not show any difference between groups (results not 235 shown). The gene expression of pro-collagens type I, III and fibronectin were measured 236 and are reported in figure 3. There was a clear disease effect towards an increase in the 237 expression of pro-collagen I in the AR groups and a trend in the same direction for pro-238 collagen III (p=0.06) but post hoc testing was not significant. We did not find any diet 239 effect on pro-collagen I gene expression. There was however a clear diet effect 240
suggesting an increased expression of pro-collagen III in the fructose-fed animals but 241 again this did not reach statistical significance after post hoc testing of the ANOVA 242 results. Fibronectin expression was unaffected in all 4 groups without any measurable 243 effect of the diet or the disease. 244
245
Myocardial metabolic enzymes 246
Data analysis suggested a disease effect on the level of LV enzymatic activity of HADH 247 (hydroxyacyl-Coenzyme A dehydrogenase), the Complex 1 of the mitochondrial electron 248 transport chain (ETC-1) and creatine kinase (CK) but not on citrate synthase (CS) or 249 succinate dehydrogenase (SDH)/ETC-2 activities (Figure 4 ). Post hoc analysis did not 250 reveal any significant differences however for these activity levels. There were no 251 significant diet effects on the enzymatic activities reported in figure 4. However we did 252 find a significant diet-disease interaction for the SDH/ETC-2 activity and this increase in 13 the ARF compared to the ARC was statistically significant. Total creatine kinase activity 254 was lower in both AR groups (Fig. 4e ) but no statistically significant diet effect or diet-255 disease interaction was found. Phosphofructokinase activity remained unchanged 256 between all 4 groups (results not shown). 257
258
The increase in circulating triglycerides in fructose-fed animals (SF and ARF) was not 259 accompanied by any changes in the mRNA levels of fatty acid transporters (FAT/CD 36 260 and carnitine palmitoyl transferases (Cpt)) although AR seemed to induce a slight 261 decrease in Cpt2 gene expression which did not reach statistical significance (Fig. 5a-c) . 262
Glucose entry in the cardiac cell is mainly mediated by glucose transporters 1 and 4 263 (GLUT 1 and GLUT4). GLUT4 mRNA expression levels remained similar between SC 264 and ARC animals. The fructose diet tended to increase this gene expression in SF and 265 not in ARF group but this did not reach statistical significance ( Fig. 5d-e) . On the other 266 hand, mRNA levels encoding for insulin-independent GLUT1 increased in both AR 267 groups compared to SC rats. Again post hoc testing was not significant. 268
Peroxisome proliferator-activated receptor alpha (PPARα) is a main regulator of fatty 269 acid metabolism. In our AR animals, LV mRNA levels of PPARα were slightly reduced 270 but the diet had no significant effect on this parameter (Figure 5f ). 271
The AKT/mTOR is a known prohypertrophic signaling pathway. We did not observe any 272 modulation of this signaling pathway in the LVs of our animals as illustrated in Figure 6 . 273
Although the total protein content of AKT and 4EBP1 (a downstream effector of mTOR) 274
were different in the SF group compared to controls, this did not translate to the content 275 of their phosphorylated form (AKT (Ser473) and 4EBP1 (Ser65)). AR-induced LV 276 hypertrophy was accompanied by a significant decrease in the content of the 277 phosphorylated form of AMPKα (Thr172). The fructose diet had a similar effect on this 278 parameter. Activation of LKB1, an AMPK regulator, was not significantly affected by the 279 diet or the disease (Figure 7) . 280
281
Discussion 282 In this study, we show in that a relatively short exposition (8 weeks) to a fructose-rich 283 diet increases eccentric LVH and slightly decreases LV ejection fraction in rats with 284 severe volume overload from aortic valve regurgitation. 285
Rats can cope with this type of LV volume overload and tolerated severe LV dilation for 286 a relatively long period with survival rates of more than 70% 6 months post AR-induction 287 (22; 32). The present protocol was relatively short-termed and evaluated the 288 compensated phase of the disease when LV dilation is almost maximal (30) but systolic 289 function remains in the normal range. Despite this relatively short exposition to the high-290 fructose diet, we report a clear increase in LVH in the AR rats. We previously reported a 291 clear link between the extent of LV hypertrophy and survival in our model (22) . In the 292 present study the AR animals fed with the high fructose diet for only 2 months had a 293 larger heart and a lower ejection fraction than the AR animals fed with the control diet. 294
This suggests that in the longer term the fructose-fed AR animals would probably have a 295 poorer survival. This issue needs to be addressed in a longer study. 296
297
Cardiac disease in patients is often accompanied by metabolic abnormalities such as 298 dyslipidemia, obesity, hypertension, insulin resistance or diabetes. The fructose-fed AR 299 rat model provides an interesting glimpse at the impact of diet-induced metabolic 300 abnormalities in the context left ventricular hypertrophy but this type of diet has never 301 been studied in a model of chronic LV volume overload with eccentric LVH (27). The 302 ARF animals were not only hypertriglyceridemic but also had more retroperitoneal fat, a 303 tendency for higher blood glucose levels and higher systolic blood pressure than those 304 from the ARC group. The sham animals fed a high-fructose diet (SF) had similar 305 metabolic abnormalities and hypertriglyceridemia than the ARF but they did not develop 306 any LVH, LV dilatation or decrease in ejection fraction compared to the sham controls. It 307 therefore seems that the AR animals coped less well with the metabolic challenge 308 imposed by the high-fructose diet than healthy animals. 309
The reasons for this different behavior are not clear. We have previously reported that 310 the sympathetic and renin-angiotensin systems are over-activated in our AR rats (27) . 311
The human metabolic syndrome has also been linked to an over-activation of the 312 sympathetic and renin-angiotensin systems (11, 26) . It is possible in our model that the 313 chronic stress imposed by AR and the hyper-adrenergic state predisposed the ARF rats 314 to have more difficulties in coping with the metabolic stress of the diet than the sham 315 rats (17; 18). 316
The precise mechanisms responsible for the increased heart hypertrophy and 317 decreased LV ejection fraction in AR rats fed with the high-fructose diet compared to 318 those fed a normal chow remain to be elucidated. They are most probably related to a 319 combination of multiple interacting factors involving several regulating pathways but 320 based on our data they do not seem to be related to ANP or BNP activation or to 321 differences in hemodynamic load. Increased LVH could be linked to increased insulin-322 triggered protein synthesis from the presence of high concentration of carbohydrates in 323 this diet. However, we did not observe any increase in Akt activation in our animals. 324
We observed decreased levels of AMP kinase activation in SF and both AR groups. This 325 observation may be important. The high fructose diet is associated with an increase in 326 circulating triglycerides and fatty acid which may cause an overabundance of substrate 327 for the myocardium (9) thus possibly reducing the need for the stimulating action of 328 AMPK on fatty acid oxidation and glycolysis (14; 15). In the short term, the myocardium 329 can probably cope with this situation as we did not observe any clear changes in the 330 level of activity of metabolic LV enzymes except for succinate dehydrogenase/ECT-2 331 activity levels. It was shown in a model of ischemic cardiomyopathy that AMPK was 332 activated but it is not clear if this is good or bad for the heart (14; 35). The same 333 observation was made in a model of pressure overload (1). In our model the observation 334 of AMPK inhibition may be related to the fact that we are still in the early stages of the 335 disease. The findings may be different later in the evolution of the disease when animals 336 start dying maybe due to a progressive incapacity of the myocardium to fulfill its need in 337 energy production. 338
The accumulation of collagen is a late feature in our AR model and only occurs after 6-9 339 months (22; 31; 32). Therefore we did not expect to find any significant changes in 340 collagen content in the myocardium of the animals after only 8 weeks. We observed a 341 trend towards an increase in pro-collagen I expression and for an increase in pro-342 collagen III expression in the fructose groups compared to the ones fed with the 343 standard diet. It is likely that this would translate into an increase in myocardial fibrosis 344 after a longer follow-up and maybe an earlier deterioration of diastolic function in theLVH and heart failure are usually associated with a shift from normal fatty acid to 347 glucose as the preferred myocardial fuel (36). In our model, this shift was not clearly 348 present after 8 weeks. Total creatine kinase, the complex 1 of the electron transport 349 chain as well as succinate dehydrogenase (SDH)/ETC-2 enzymatic activities were 350 reduced in AR rats suggesting a possible early alteration of mitochondrial function in 351 these animals. Surprisingly, SDH activity seemed restored in AR animals on the fructose 352 diet. The SDH/ETC-2 links the Krebs cycle to the electron transport chain (3). On one 353 hand, this may be seen as a positive effect of the fructose diet by maintaining normal 354 levels of SDH activity in the Krebs cycle. On the other hand, if the ETC function is 355 impaired in the heart of AR animals, an increase in complex II activity by the fructose 356 diet could be associated with an increase in reactive oxygen species production (19) . 357
This protocol unfortunately was not designed to test this hypothesis. 358
The impact of the fructose diet on some myocardial enzymatic activities seemed 359 different in AR animals compared to sham controls. The shams on the fructose diet did 360 not develop any hypertrophy or sign of LV dysfunction. How the dilated and 361 hypertrophied left ventricle adapts to the high-fructose diet compared to a normal left 362 ventricle and why it develops more hypertrophy remain a mystery. AR is associated with 363 a decreased gene expression of PPARα which is known to stimulate fatty acid oxidation 364 (34). The overabundance of circulating triglycerides combined with a lack of increase in 365 fatty acid oxidation by the heart could possibly lead to myocardial lipotoxicity but this 366 remains a hypothesis to be confirmed. The fructose diet slightly increased FAT/CD36 367 expression in both sham and AR animals. We previously observed that myocardialan excess of fatty acid substrate with a similar or reduced capacity for β-oxidation may 371 develop lipotoxicity (6) . This hypothesis will be tested in a specifically designed protocol. 372
373
Study limitations: 374
The results of this study have to be viewed in light of some limitations. Rodent heart 375 metabolism may differ in some aspects from human heart metabolism. Substrate 376 utilization was not directly assessed in vivo. The high fructose diet had a slightly higher 377 fat content (5,2% vs. 4,5%) and lower caloric content (3,6 kCal/g vs 4,0 kCal/g) 378 compared to the control diet. The impacts of a longer exposition to the abnormal diet 379 have to be evaluated in longer protocols. Other signaling pathways potentially involved 380 need to be investigated in more details 381 382
Conclusions: 383
The results of this study show that a short exposition (8 weeks) to a high fructose diet is 384 sufficient to worsen LV eccentric hypertrophy and LV function in rats with volume 385 overload due to severe aortic valve regurgitation. Exposing AR rats to this high fructose 386 diet resulted in hypertriglyceridemia, a higher retroperitoneal fat content and a trend for 387 higher glycemia and higher systolic blood pressure than those fed a normal diet. Put 388 together, these results suggest that a high fructose diet has a clear, rapid and negative 389 impact on the myocardium and on the metabolic profile of rats already suffering from a 390 chronic stress such as volume overload. The exact mechanisms involved and 391 consequences for the heart will need to be explored in longer studies. Our current 392 findings in conjunction of those of other authors (37-39) working on LVH pressure-393 overload models strongly point toward a deleterious role of high fructose consumption in
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